Mammatyper logo

You’re most likely here because either you, or someone you care about has been diagnosed with Breast Cancer. We understand how confusing all the information can be so we have tried to make it as simple as we can to help you ask the right questions to your clinical care team.

As you probably know, Breast Cancer is not one disease, it is broken down into several types – each of which will respond differently to treatment.

When Breast Cancer tissue is examined by pathologists, it is subtyped to help determine what sort of cells it contains and therefore what type of treatment it is more likely to respond to. Currently this process is usually done manually and pathologists do a good job, however the procedure has been little-changed in almost 50 years. There have obviously been huge leaps in medical technology in the intervening period and now it’s time to bring Breast Cancer diagnostics into the 21st Century.

MammaTyper® is a real-time, quantitative PCR (RT-qPCR) test. You may well have heard a lot about this technology over the past couple of years as it has been used to diagnose Covid 19. In the case of Breast Cancer, rapid PCR testing can quickly and accurately subtype tissue whilst removing the margin for human error. It provides doctors with a solid foundation to discuss with their patients the best and likely most effective treatment options for their particular case.

Having an accurate diagnosis is so important. Without this foundation on which to base treatment plans, it is impossible to know what will work. RT-qPCR tests are relatively new and should complement the excellent work that the clinical teams are doing, but it’s worth asking the question – how was my case subtyped?

BREAST CANCER

Overview

icon_overview_mammatyper_patient

Accurate determination of molecular subtypes is one of several key elements for defining the optimal therapy strategy.

READ MORE +

BREAST CANCER

Detection and diagnosis

icon_detenction_and_diagnosis_mammatyper_patient

MammaTyper helps pathologists to overcome limitations of semi-quantitative staining methods.

READ MORE +

BREAST CANCER

Biomarkers

icon_biomarkers_mammatyper_patient

MammaTyper  precisely determines mRNA expression of ER, PR, HER2 and Ki-67

READ MORE +

BREAST CANCER

Subtyping

icon_subtyping_mammatyper_patient

MammaTyper  results ensure precise determination of breast cancer subtypes correlated with clinical outcome

READ MORE +

BREAST CANCER

Therapy

icon_therapy_mammatyper_patient

Today there is a wide selection of treatments available to fight each individual Breast Cancer type.

READ MORE +

BREAST CANCER

FAQ

icon_faq_mammatyper_patient

Patient support and education is key to what we are trying to do here at Cerca Biotech in our mission to make pioneering change within Oncology

READ MORE +

BREAST CANCER

Glossary

icon_glossary_and_diagnosis_mammatyper_patient

From A to Z

READ MORE +